This Sarepta Therapeutics Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

JP Morgan analyst Anupam Rama upgraded Sarepta Therapeutics, Inc. SRPT from Underweight to Neutral and announced a $24 price target. Sarepta Therapeutics shares closed at $13.86 on Monday. See how other analysts view this stock.
B of A Securities analyst Andrew Obin upgraded Allegion plc ALLE from Underperform to Neutral and raised the price target from $110 to $175. Allegion shares closed at $163.67 on Monday. See how other analysts view this stock.
Macquarie analyst Tao Qiu upgraded the rating for Healthcare Services Group, Inc. HCSG from Neutral to Outperform and boosted the price target from $15 to $16. Healthcare Services Group shares closed at $13.25 on Monday. See how other analysts view this stock.
Raymond James analyst Alexander Sklar upgraded BlackLine, Inc. BL from Market Perform to Outperform and announced a $67 price target. BlackLine shares closed at $55.70 on Monday. See how other analysts view this stock.
Citigroup analyst Leandro Bastos upgraded Afya Limited AFYA from Sell to Neutral and lowered the price target from $16 to $14. Afya shares closed at $13.83 on Monday. See how other analysts view this stock.